ALK7 RNA interference agents

TW202641565APending Publication Date: 2026-10-16ELI LILLY & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145467
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-31
Filing Date
2025-11-21
Publication Date
2026-10-16

Smart Images

  • Figure 00000093_0000
    Figure 00000093_0000
Patent Text Reader

Abstract

Provided herein are ALK7 RNAi agents, conjugates thereof, and compositions comprising an ALK7 RNAi agent. Also provided herein are methods of using the ALK7 RNAi agents or compositions comprising an ALK7 RNAi agent for reducing ACVR1C expression, and / or treating ALK7 associated metabolic disorder in a subject.
Need to check novelty before this filing date? Find Prior Art